Neuronal NO Mediates Cerebral Vasodilator Responses to K+ in Hypertensive Rats

S. Chrissobolis, J. Ziogas, C. Anderson, Y. Chu, F. Faraci, C. Sobey
{"title":"Neuronal NO Mediates Cerebral Vasodilator Responses to K+ in Hypertensive Rats","authors":"S. Chrissobolis, J. Ziogas, C. Anderson, Y. Chu, F. Faraci, C. Sobey","doi":"10.1161/01.HYP.0000013056.74554.CE","DOIUrl":null,"url":null,"abstract":"Potassium ion (K+) normally causes cerebral vasodilatation by activating inwardly rectifying K+ (KIR) channels. We tested whether chronic hypertension affects the magnitude and/or mechanism of K+-induced cerebral vasodilatation in vivo. Basilar artery responses were examined in anesthetized Wistar-Kyoto (WKY; mean arterial pressure, 114±4 mm Hg) and spontaneously hypertensive (SHR; 176±3 mm Hg) rats. In WKY, elevating cerebrospinal fluid K+ concentration from 3 mmol/L to 5 and 10 mmol/L caused vasodilatation (percent maximum, 12±1 and 48±7, respectively). The response to 5 mmol/L K+ was greater in SHR (percent maximum, 17±2 [P <0.05 versus WKY] and 49±4). The KIR channel inhibitor, barium ion (Ba2+, 100 &mgr;mol/L) selectively inhibited dilator responses to 5 and 10 mmol/L K+ by ≈75% in WKY. In SHR, Ba2+ had no effect on the response to 5 mmol/L K+, and only partially inhibited (by ≈40%) the response to 10 mmol/L K+. The nonselective NO synthase (NOS) inhibitor N&ohgr;-nitro-l-arginine methyl ester, the neuronal NOS (nNOS) inhibitor 1-(2-trifluromethyl-phenyl)imidazole, and the N-type calcium channel inhibitor &ohgr;-conotoxin GVIA, were all without effect in WKY, but markedly inhibited the response to 5 mmol/L K+ in SHR. When applied together with Ba2+, each of these inhibitors also profoundly reduced responses to 10 mmol/L K+ in SHR. Immunostaining of basilar arteries revealed that the perivascular nNOS-containing nerve plexus was denser in SHR. Thus, K+ dilates the normotensive basilar artery predominantly via KIR channel activation. During chronic hypertension, small physiological elevations in K+ dilate the basilar artery by an nNOS-dependent mechanism that appears to be upregulated in a compensatory manner.","PeriodicalId":13233,"journal":{"name":"Hypertension: Journal of the American Heart Association","volume":"1 1","pages":"880-885"},"PeriodicalIF":0.0000,"publicationDate":"2002-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"18","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hypertension: Journal of the American Heart Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/01.HYP.0000013056.74554.CE","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 18

Abstract

Potassium ion (K+) normally causes cerebral vasodilatation by activating inwardly rectifying K+ (KIR) channels. We tested whether chronic hypertension affects the magnitude and/or mechanism of K+-induced cerebral vasodilatation in vivo. Basilar artery responses were examined in anesthetized Wistar-Kyoto (WKY; mean arterial pressure, 114±4 mm Hg) and spontaneously hypertensive (SHR; 176±3 mm Hg) rats. In WKY, elevating cerebrospinal fluid K+ concentration from 3 mmol/L to 5 and 10 mmol/L caused vasodilatation (percent maximum, 12±1 and 48±7, respectively). The response to 5 mmol/L K+ was greater in SHR (percent maximum, 17±2 [P <0.05 versus WKY] and 49±4). The KIR channel inhibitor, barium ion (Ba2+, 100 &mgr;mol/L) selectively inhibited dilator responses to 5 and 10 mmol/L K+ by ≈75% in WKY. In SHR, Ba2+ had no effect on the response to 5 mmol/L K+, and only partially inhibited (by ≈40%) the response to 10 mmol/L K+. The nonselective NO synthase (NOS) inhibitor N&ohgr;-nitro-l-arginine methyl ester, the neuronal NOS (nNOS) inhibitor 1-(2-trifluromethyl-phenyl)imidazole, and the N-type calcium channel inhibitor &ohgr;-conotoxin GVIA, were all without effect in WKY, but markedly inhibited the response to 5 mmol/L K+ in SHR. When applied together with Ba2+, each of these inhibitors also profoundly reduced responses to 10 mmol/L K+ in SHR. Immunostaining of basilar arteries revealed that the perivascular nNOS-containing nerve plexus was denser in SHR. Thus, K+ dilates the normotensive basilar artery predominantly via KIR channel activation. During chronic hypertension, small physiological elevations in K+ dilate the basilar artery by an nNOS-dependent mechanism that appears to be upregulated in a compensatory manner.
神经元NO介导高血压大鼠对K+的脑血管舒张反应
钾离子(K+)通常通过激活向内纠偏的K+ (KIR)通道引起脑血管舒张。我们在体内测试了慢性高血压是否影响K+诱导的脑血管舒张的大小和/或机制。麻醉Wistar-Kyoto (WKY;平均动脉压,114±4mmhg)和自发性高血压(SHR;176±3mmhg)大鼠。在WKY中,脑脊液K+浓度从3 mmol/L升高到5和10 mmol/L可引起血管舒张(最大百分比分别为12±1和48±7)。5 mmol/L K+对SHR的响应更大(最大百分比为17±2 [P <0.05与WKY相比]和49±4)。KIR通道抑制剂钡离子(Ba2+, 100 mol/L)在WKY中选择性抑制5和10 mmol/L K+的扩张剂反应约75%。在SHR中,Ba2+对5 mmol/L K+的反应没有影响,对10 mmol/L K+的反应只有部分抑制(约40%)。非选择性NO合成酶(NOS)抑制剂N&ohgr;-硝基精氨酸甲酯、神经元NOS (nNOS)抑制剂1-(2-三氟甲基苯基)咪唑和n型钙通道抑制剂&ohgr;-螺毒素GVIA在WKY中均无作用,但在SHR中明显抑制5 mmol/L K+的反应。当与Ba2+一起使用时,这些抑制剂中的每一种都大大降低了SHR对10 mmol/L K+的反应。基底动脉免疫染色显示SHR患者血管周围含有nnos的神经丛较致密。因此,K+主要通过激活KIR通道来扩张正常血压的基底动脉。在慢性高血压期间,K+的小生理升高通过nnos依赖机制扩张基底动脉,该机制似乎以代偿方式上调。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信